Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
46
ACHC Quote, Financials, Valuation and Earnings
Last price:
$24.15
Seasonality move
:
2.96%
Day range:
$23.65 - $25.12
52-week range:
$11.43 - $31.04
Dividend yield:
0%
P/E ratio:
14.57x
P/S ratio:
0.66x
P/B ratio:
1.13x
Volume:
2.5M
Avg. volume:
4.1M
1-year change:
-17.96%
Market cap:
$2.2B
Revenue:
$3.3B
EPS (TTM):
-$12.20
Analysts' Opinion
-
Consensus RatingAcadia Healthcare Co., Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $22.71, Acadia Healthcare Co., Inc. has an estimated downside of -4.92% from its current price of $23.89.
-
Price Target UpsideAccording to analysts, the highest upside price target is $30.00 representing 25.58% upside increase from its current price of $23.89.
Fair Value
-
According to the consensus of 11 analysts, Acadia Healthcare Co., Inc. has -4.92% downside to fair value with a price target of $22.71 per share.
ACHC vs. S&P 500
-
Over the past 5 trading days, Acadia Healthcare Co., Inc. has underperformed the S&P 500 by -1.27% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Acadia Healthcare Co., Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Acadia Healthcare Co., Inc. has grown year-over-year revenues for 20 quarters straight. In the most recent quarter Acadia Healthcare Co., Inc. reported revenues of $821.5M.
Earnings Growth
-
Acadia Healthcare Co., Inc. earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Acadia Healthcare Co., Inc. reported earnings per share of -$13.02.
Enterprise value:
4.9B
EV / Invested capital:
1.03x
Price / LTM sales:
0.66x
EV / EBIT:
12.67x
EV / Revenue:
1.48x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-11.18x
Price / Operating cash flow:
81.81x
Enterprise value / EBITDA:
8.52x
Gross Profit (TTM):
$583.4M
Return On Assets:
-17.99%
Net Income Margin (TTM):
-32.96%
Return On Equity:
-36.35%
Return On Invested Capital:
-20.29%
Operating Margin:
5.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $2.9B | $3.2B | $3.3B | $774.2M | $821.5M | |
| Gross Profit | $682.6M | $712M | $583.4M | $150.9M | $96M | |
| Operating Income | $506.6M | $522.3M | $388M | $103.5M | $47.6M | |
| EBITDA | $638.9M | $671.9M | $577.2M | $143M | $93.4M | |
| Diluted EPS | -$0.25 | $2.78 | -$12.20 | $0.35 | -$13.02 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $495M | $506.1M | $596M | $577.5M | $814.1M | |
| Total Assets | $4.8B | $5B | $5.4B | $6B | $5.5B | |
| Current Liabilities | $404.9M | $388.3M | $885.8M | $577.9M | $525.2M | |
| Total Liabilities | $2.2B | $2.1B | $2.5B | $2.8B | $3.4B | |
| Total Equity | $2.6B | $2.9B | $2.9B | $3.2B | $2.1B | |
| Total Debt | $1.6B | $1.5B | $1.5B | $2.1B | $2.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $462.3M | $129.7M | $131.9M | $116.7M | -$86.3M | |
| Cash From Investing | -$397.2M | -$736.5M | -$556.2M | -$203.3M | -$92.4M | |
| Cash From Financing | -$62.7M | $583M | $481.3M | $80.8M | $193.3M | |
| Free Cash Flow | $38.2M | -$560.7M | -$439.9M | -$86.8M | -$179.5M | |
ACHC
Sector
Market Cap
$2.2B
$25.8M
Price % of 52-Week High
76.97%
49.8%
Dividend Yield
0%
0%
Shareholder Yield
-6.15%
-1.68%
1-Year Price Total Return
-17.96%
-17.36%
Beta (5-Year)
0.741
0.492
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$24.32
200-day SMA
Buy
Level
$19.93
Bollinger Bands (100)
Buy
Level
13.21 - 21.37
Chaikin Money Flow
Buy
Level
28.6M
20-day SMA
Buy
Level
$20.54
Relative Strength Index (RSI14)
Buy
Level
69.56
ADX Line
Buy
Level
47.44
Williams %R
Sell
Level
-19.5584
50-day SMA
Buy
Level
$16.43
MACD (12, 26)
Buy
Level
2.67
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
12.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9271)
Buy
CA Score
(Annual)
Level (-0.2219)
Buy
Beneish M-Score
(Annual)
Level (-3.4503)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (0.8884)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.
Stock Forecast FAQ
In the current month, ACHC has received 5 Buy ratings 6 Hold ratings, and 0 Sell ratings. The ACHC average analyst price target in the past 3 months is $22.71.
-
Where Will Acadia Healthcare Co., Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Acadia Healthcare Co., Inc. share price will drop to $22.71 per share over the next 12 months.
-
What Do Analysts Say About Acadia Healthcare Co., Inc.?
Analysts are divided on their view about Acadia Healthcare Co., Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Acadia Healthcare Co., Inc. is a Sell and believe this share price will rise from its current level to $13.00.
-
What Is Acadia Healthcare Co., Inc.'s Price Target?
The price target for Acadia Healthcare Co., Inc. over the next 1-year time period is forecast to be $22.71 according to 11 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is ACHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Acadia Healthcare Co., Inc. is a Hold. 6 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ACHC?
You can purchase shares of Acadia Healthcare Co., Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Acadia Healthcare Co., Inc. shares.
-
What Is The Acadia Healthcare Co., Inc. Share Price Today?
Acadia Healthcare Co., Inc. was last trading at $24.15 per share. This represents the most recent stock quote for Acadia Healthcare Co., Inc.. Yesterday, Acadia Healthcare Co., Inc. closed at $23.89 per share.
-
How To Buy Acadia Healthcare Co., Inc. Stock Online?
In order to purchase Acadia Healthcare Co., Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ACHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ACHC
Sector
P/E ratio
14.57x
21.71x
PEG ratio
--
-0.01x
P/B ratio
1.13x
1.78x
Price / LTM sales
0.66x
1.49x
Growth Metrics
ACHC
Sector
Revenue growth
6.1%
3.28%
Earnings growth
-3771.63%
11.93%
Revenue (5-year growth)
9.65%
6.26%
Earnings forecast
$0.01
-$0.20
Profitability
ACHC
Sector
Profitability FY 2025
$583.4M
$2.3M
Return on invested capital
-20.29%
-33.25%
Return on assets
-17.99%
-29.94%
Return on equity
-36.35%
-40.01%
Earnings Date
Last Earnings Date
Feb
25
Next Earnings Date
May
11
Estimated Next Earnings Date
May
27
Balance Sheet
ACHC
Sector
Total cash
$133.2M
$25M
Short term investments
--
$23.2M
Total assets
$5.5B
$70.1M
Long term debt
$2.6B
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 29x
Alerts
Buy
52
PZZA alert for Mar 12
Papa John's International, Inc. [PZZA] is down 7.08% over the past day.
Buy
53
NBIS alert for Mar 12
Nebius Group NV [NBIS] is down 3.56% over the past day.
Buy
88
NBTX alert for Mar 12
Nanobiotix SA [NBTX] is down 4.42% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
